• locale

  United States

• market

  PRIVATE

• industry

  Biotechnology

• website

  lealtx.com/

Leal Therapeutics is developing precision medicines for central nervous system (CNS) disorders, focusing on therapies for conditions such as ALS, schizophrenia, and Alzheimer’s disease. The company is working on multiple programs, with clinical data expected in 2025.